{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:34:29Z","timestamp":1791351269249,"version":"4.3.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570497"],"award-info":[{"award-number":["81570497"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","award":["cstc2020jcyj-bshX0116"],"award-info":[{"award-number":["cstc2020jcyj-bshX0116"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cbi.2022.109796","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T02:33:47Z","timestamp":1641522827000},"page":"109796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma"],"prefix":"10.1016","volume":"353","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-2750","authenticated-orcid":false,"given":"Xiaoyan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maocheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.109796_bib1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.109796_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2022.109796_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cbi.2022.109796_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720109","article-title":"Monocytes and macrophages in COVID-19","volume":"12","author":"Knoll","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2022.109796_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102833","article-title":"Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients","volume":"57","author":"Wang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cbi.2022.109796_bib6","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1172\/JCI124918","article-title":"Osteopontin controls immunosuppression in the tumor microenvironment","volume":"128","author":"Shurin","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2022.109796_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2022.109796_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.seminoncol.2021.01.003","article-title":"Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center","volume":"48","author":"Fernandes","year":"2021","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib10","first-page":"3868","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as mortality predictor of advanced stage non-small cell lung cancer (NSCLC) with COVID-19 in Indonesia","volume":"25","author":"Sutandyo","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2022.109796_bib11","first-page":"335","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, the Lancet","volume":"21","author":"Liang","year":"2020","journal-title":"Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib12","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","article-title":"COVID-19 in patients with lung cancer","volume":"31","author":"Luo","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib13","doi-asserted-by":"crossref","first-page":"102972","DOI":"10.1016\/j.critrevonc.2020.102972","article-title":"Cancer patients and research during COVID-19 pandemic: a systematic review of current evidence","volume":"150","author":"Moujaess","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cbi.2022.109796_bib14","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1016\/j.annonc.2021.05.649","article-title":"MO33-5 the impact of chemotherapy for cancer patients with COVID-19 on severity and mortality outcomes: a meta-analysis","volume":"32","author":"Hariyanto","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.cbi.2022.109796_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cbi.2022.109796_bib17","first-page":"1","article-title":"Retracted article: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion","author":"Wang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cbi.2022.109796_bib18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jmv.25980","article-title":"DC\/L-SIGNs of hope in the COVID-19 pandemic","volume":"92","author":"Brufsky","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2022.109796_bib19","first-page":"601","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26, Emerg","volume":"9","author":"Vankadari","year":"2020","journal-title":"Microb. Infect."},{"key":"10.1016\/j.cbi.2022.109796_bib20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cbi.2022.109796_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008461","article-title":"Targeting TMPRSS2 and Cathepsin B\/L together may be synergistic against SARS-CoV-2 infection","volume":"16","author":"Padmanabhan","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cbi.2022.109796_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cbi.2022.109796_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","article-title":"Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis","volume":"591","author":"Johnson","year":"2021","journal-title":"Nature"},{"issue":"39","key":"10.1016\/j.cbi.2022.109796_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104759118","article-title":"Orthogonal genome-wide screens of bat cells identify MTHFD1 as a target of broad antiviral therapy","volume":"118","author":"Anderson","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cbi.2022.109796_bib25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe covid-19 with respiratory failure","volume":"383","author":"Ellinghaus","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2022.109796_bib26","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/cid\/ciaa587","article-title":"COVID-19 pandemic: time to revive the cyclophilin inhibitor alisporivir","volume":"71","author":"Pawlotsky","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cbi.2022.109796_bib27","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.7150\/ijbs.48639","article-title":"Bioinformatic analysis of correlation between immune infiltration and COVID-19 in cancer patients","volume":"16","author":"Huang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2022.109796_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13045-020-00883-5","article-title":"Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis","volume":"13","author":"Chai","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3892\/ijo.2020.5071","article-title":"Pan-cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS-CoV-2 infection leading to COVID-19","volume":"57","author":"Katopodis","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib30","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/0008-5472.CAN-11-1403","article-title":"Identification of genes upregulated in ALK-positive and EGFR\/KRAS\/ALK-negative lung adenocarcinomas","volume":"72","author":"Okayama","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2022.109796_bib31","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1349-7006.2012.02367.x","article-title":"Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins\/cyclin-dependent kinases and the phosphoinositide 3-kinase\/AKT signaling cascade","volume":"103","author":"Wei","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cbi.2022.109796_bib32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2164-8-140","article-title":"Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme","volume":"8","author":"Su","year":"2007","journal-title":"BMC Genom."},{"key":"10.1016\/j.cbi.2022.109796_bib33","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1158\/1055-9965.EPI-10-0332","article-title":"Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women","volume":"19","author":"Lu","year":"2010","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cbi.2022.109796_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.5483\/BMBRep.2018.51.12.205","article-title":"SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker","volume":"51","author":"Xu","year":"2018","journal-title":"BMB Rep."},{"key":"10.1016\/j.cbi.2022.109796_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105639","article-title":"Gene expression profiling in human lung development: an abundant resource for lung adenocarcinoma prognosis","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.109796_bib36","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1101\/gr.132662.111","article-title":"Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression","volume":"22","author":"Selamat","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.cbi.2022.109796_bib37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.1790","article-title":"Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study","volume":"14","author":"Shedden","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2022.109796_bib38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature07423","article-title":"Somatic mutations affect key pathways in lung adenocarcinoma","volume":"455","author":"Ding","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.109796_bib39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/JTO.0000000000000560","article-title":"An integrated prognostic classifier for stage I lung adenocarcinoma based on mRNA, microRNA, and DNA methylation biomarkers","volume":"10","author":"Robles","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib40","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/onc.2015.375","article-title":"Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma","volume":"35","author":"Schabath","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2022.109796_bib41","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1158\/1078-0432.CCR-13-0341","article-title":"ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer","volume":"19","author":"Kabbout","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2022.109796_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001651","article-title":"Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival","volume":"3","author":"Landi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.109796_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010312","article-title":"Gene expression-based classification of non-small cell lung carcinomas and survival prediction","volume":"5","author":"Hou","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.109796_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.cbi.2022.109796_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.cbi.2022.109796_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cbi.2022.109796_bib47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.stem.2020.10.005","article-title":"Human lung stem cell-based alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and pneumocyte dysfunction","volume":"27","author":"Katsura","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.cbi.2022.109796_bib48","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1038\/s41467-021-25156-8","article-title":"SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters","volume":"12","author":"Port","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2022.109796_bib49","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cbi.2022.109796_bib50","doi-asserted-by":"crossref","first-page":"6635925","DOI":"10.1155\/2021\/6635925","article-title":"Whole-Transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID-19 patients","author":"Li","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cbi.2022.109796_bib51","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","article-title":"COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas","volume":"184","author":"Ren","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.109796_bib52","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"Franceschini","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2022.109796_bib53","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.cbi.2022.109796_bib54","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2022.109796_bib55","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2022.109796_bib56","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2022.109796_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-2-18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.cbi.2022.109796_bib58","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.cbi.2022.109796_bib59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2022.109796_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cbi.2022.109796_bib61","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3389\/fimmu.2020.01580","article-title":"Severe COVID-19: NLRP3 inflammasome dysregulated","volume":"11","author":"van den Berg","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2022.109796_bib62","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2022.109796_bib63","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.109796_bib64","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2022.109796_bib65","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cbi.2022.109796_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254258","article-title":"Variable effects of underlying diseases on the prognosis of patients with COVID-19","volume":"16","author":"Choi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.109796_bib67","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-020-01209-2","article-title":"Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection","volume":"19","author":"Kong","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2022.109796_bib68","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/jmv.26107","article-title":"Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer","volume":"92","author":"Ilikci Sagkan","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2022.109796_bib69","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.7150\/jca.49462","article-title":"Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.cbi.2022.109796_bib70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacbts.2020.09.010","article-title":"Cardiorenal tissues express SARS-CoV-2 entry genes and basigin (BSG\/CD147) increases with age in endothelial cells","volume":"5","author":"Ahmetaj-Shala","year":"2020","journal-title":"JACC Basic Transl. Sci"},{"key":"10.1016\/j.cbi.2022.109796_bib71","doi-asserted-by":"crossref","first-page":"624899","DOI":"10.3389\/fonc.2021.624899","article-title":"Landscape profiling analysis of DPP4 in malignancies: therapeutic implication for tumor patients with coronavirus disease 2019","volume":"11","author":"Shu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cbi.2022.109796_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40200-021-00777-4","article-title":"Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Hariyanto","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.cbi.2022.109796_bib73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cbi.2022.109796_bib74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","article-title":"Multi-organ proteomic landscape of COVID-19 autopsies","volume":"184","author":"Nie","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.109796_bib75","doi-asserted-by":"crossref","first-page":"nwab143","DOI":"10.1093\/nsr\/nwab143","article-title":"Postmortem tissue proteomics reveals the pathogenesis of multiorgan injuries of COVID-19","volume":"8","author":"Qiu","year":"2021","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.cbi.2022.109796_bib76","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2022.109796_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.02.035","article-title":"Cathepsin B: a sellsword of cancer progression","volume":"449","author":"Mijanovi\u0107","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2022.109796_bib78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume":"19","author":"Bruchard","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2022.109796_bib79","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1007\/s10753-021-01477-0","article-title":"Downregulation of cathepsin B reduces proliferation and inflammatory response and facilitates differentiation in human HaCaT keratinocytes, ameliorating IL-17A and SAA-induced psoriasis-like lesion","volume":"44","author":"Xu","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.cbi.2022.109796_bib80","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jdermsci.2013.06.014","article-title":"Administration of cathepsin B inhibitor CA-074Me reduces inflammation and apoptosis in polymyositis","volume":"72","author":"Feng","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cbi.2022.109796_bib81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/labinvest.2014.135","article-title":"Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis","volume":"95","author":"Zhang","year":"2015","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cbi.2022.109796_bib82","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2741\/3255","article-title":"Cystatins and cancer","volume":"14","author":"Cox","year":"2009","journal-title":"Front. in bio. (Landmark edition)"},{"key":"10.1016\/j.cbi.2022.109796_bib83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fphar.2012.00133","article-title":"Differential impact of cysteine cathepsins on genetic mouse models of de novo carcinogenesis: cathepsin B as emerging therapeutic target","volume":"3","author":"Reinheckel","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2022.109796_bib84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1006524321335","article-title":"Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B","volume":"16","author":"Van Noorden","year":"1998","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.cbi.2022.109796_bib85","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-11-2759","article-title":"Cathepsin B inhibition limits bone metastasis in breast cancer","volume":"72","author":"Withana","year":"2012","journal-title":"Cancer Res."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:05:11Z","timestamp":1757858711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":85,"alternative-id":["S0009279722000011"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109796","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.109796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109796"}}